Medical device
Reports that the online retailer wants to become a major hospital supplier is giving some in medtech reason to worry.
The company’s study included 105 kids, ages 7 to 13.
The company submitted the infringement suit this week to the U.S. District Court for the Southern District of California.
1315 Capital focuses on early to mid-stage investments primarily for pharma and medtech companies.
The company plans to build two new cleanrooms and a sterilisation suite at its manufacturing base at Inchinnan.
The device, which is shaped to mimic the natural geometry of human vasculature, compared favorably with drug-coated balloons and stents.
The lawsuit alleged that Insulet misrepresented the success of its OmniPod Eros roll-out in 2013.
The federal watchdog has cleared the updated design and labeling for the duodenoscope.
The Dutch healthcare giant said that it also plans to invest in a service training program in Cleveland.
PRESS RELEASES